Fungal infections in transplant and oncology patients.
Recent shifts in the epidemiology of invasive fungal infections (IFIs) among transplant and oncology populations have led to new recommendations on treatment; however, they have also brought new controversies. New pharmacologic therapies are being studied and guidelines for management of several IFIs have been changed accordingly. More information is being discovered about unique genetic factors that put some transplant recipients at greater risk than others for fungal infection. The role of immunomodulation continues to be investigated, and the delicate balance of maintaining some immune integrity while assuring protection of the graft remains critical. For transplant and oncology patients, the diagnosis and management of IFIs remain challenging, and improving outcomes depends on continued progress in all of these arenas. This article highlights recent advances and important factors to consider when treating transplant and oncology patients with IFIs.
Person
Anna K
AK
Division of Infectious Diseases, Department of Medicine, Duke University Health System, Duke University School of Medicine, Box 102359, Durham, NC 27710, USA. perso006@mc.duke.edu
Kontoyiannis
Dimitrios P
DP
Alexander
Barbara D
BD
D064420:Drug-Related Side Effects and Adverse Reactions; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*; D009369:Neoplasms / Q000188:drug therapy*; D016377:Organ Transplantation / Q000009:adverse effects*
D007166:Immunosuppressive Agents
Clin Infect Dis. 2004 May 1;38(9):1237-42
15127334
Bone Marrow Transplant. 2007 Apr;39(7):425-9
17310132
Clin Microbiol Rev. 2000 Apr;13(2):236-301
10756000
Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):99-109
1396746
J Clin Microbiol. 2008 Aug;46(8):2568-72
18562581
Transpl Infect Dis. 2006 Dec;8(4):213-8
17116134
N Engl J Med. 1994 Nov 17;331(20):1325-30
7935701
Clin Infect Dis. 2000 Jun;30(6):851-6
10852735
N Engl J Med. 1992 Mar 26;326(13):845-51
1542320
J Heart Lung Transplant. 1998 Oct;17(10):1029-33
9811413
Clin Infect Dis. 2003 Jul 15;37(2):221-9
12856215
Clin Infect Dis. 2005 Jun 15;40(12):1756-61
15909263
Clin Infect Dis. 2009 Mar 15;48(6):772-86
19207081
Clin Infect Dis. 2002 Apr 1;34(7):909-17
11880955
Clin Infect Dis. 2009 Mar 1;48(5):503-35
19191635
J Infect Dis. 2007 Mar 1;195(5):756-64
17262720
Eur J Clin Microbiol Infect Dis. 2007 Dec;26(12):879-86
17874329
Bone Marrow Transplant. 2006 May;37(9):857-64
16532017
Clin Infect Dis. 2002 Apr 15;34(8):1098-107
11914999
Med Mycol. 2006 Aug;44(5):445-9
16882611
Clin Infect Dis. 1993 Jan;16(1):54-8
8448319
J Immunol. 1988 Mar 15;140(6):2023-31
3257995
Clin Infect Dis. 2004 Aug 15;39(4):584-7
15356827
N Engl J Med. 2007 Jun 14;356(24):2472-82
17568028
N Engl J Med. 2000 Oct 19;343(16):1163-6
11036122
Eur J Clin Microbiol Infect Dis. 2006 Jun;25(6):382-8
16767486
Lancet. 2007 May 5;369(9572):1519-1527
17482982
Antimicrob Agents Chemother. 2007 Jul;51(7):2587-90
17452481
J Infect. 2005 Jun;50(5):443-9
15907554
Clin Infect Dis. 2002 Aug 15;35(4):359-66
12145716
Ann Intern Med. 1982 Feb;96(2):159-63
7059062
Clin Infect Dis. 2007 Jan 1;44(1):2-12
17143808
Cancer. 2006 Dec 15;107(12):2888-97
17103444
Transpl Infect Dis. 2002 Dec;4(4):195-200
12535262
Clin Infect Dis. 2003 Mar 15;36(6):789-94
12627365
Clin Infect Dis. 2000 Apr;30(4):710-8
10770733
J Infect Dis. 1977 Jul;136(1):43-9
328785
PLoS Med. 2007 Feb;4(2):e21
17284154
Bone Marrow Transplant. 1999 Aug;24(3):307-12
10455371
N Engl J Med. 2002 Dec 19;347(25):2020-9
12490683
Clin Infect Dis. 2003 Nov 1;37(9):1172-7
14557960
Clin Infect Dis. 2008 Aug 15;47(4):503-9
18611163
N Engl J Med. 2002 Aug 8;347(6):408-15
12167683
Clin Infect Dis. 2003 Nov 1;37(9):1265-9
14557974
Infect Dis Clin North Am. 2006 Sep;20(3):507-44, v-vi
16984867
Transpl Int. 2007 Dec;20(12):993-1015
17617181
Clin Transplant. 1996 Apr;10(2):160-5
8664511
Antimicrob Agents Chemother. 2004 Sep;48(9):3217-25
15328076
Transpl Infect Dis. 2005 Sep-Dec;7(3-4):109-15
16390398
J Heart Lung Transplant. 2003 Mar;22(3):258-66
12633692
Clin Infect Dis. 2001 Nov 1;33(9):1536-44
11588699
Am J Transplant. 2004 Apr;4(4):636-43
15023157
Clin Infect Dis. 1995 Jan;20(1):115-25
7727637
Clin Infect Dis. 2005 Jan 1;40(1):89-99
15614697
Clin Lab Med. 1995 Jun;15(2):365-87
7671578
Am J Med. 1997 Aug;103(2):106-13
9274893
Clin Infect Dis. 2009 Feb 1;48(3):265-73
19115967
Clin Infect Dis. 2008 Aug 1;47(3):364-71
18558882
Transpl Infect Dis. 2007 Dec;9(4):310-7
17428278
Clin Infect Dis. 2001 Sep 1;33(5):690-9
11477526
Antimicrob Agents Chemother. 2008 Jul;52(7):2636-8
18458135
Transplantation. 1986 Jun;41(6):725-9
3012834
Clin Infect Dis. 2008 Feb 1;46(3):327-60
18177225
J Am Coll Surg. 1996 Oct;183(4):307-16
8843258
J Infect. 2006 Nov;53(5):337-49
16678903
Cancer. 2007 Dec 15;110(12):2740-6
17941026
Clin Infect Dis. 2003 May 15;36(10):1221-8
12746765
Clin Microbiol Infect. 2005 May;11(5):359-65
15819861
Clin Infect Dis. 2001 Dec 1;33(11):1824-33
11692293
Br J Haematol. 2002 Feb;116(2):475-82
11841455
J Antimicrob Chemother. 1998 Oct;42(4):497-502
9818749
Clin Infect Dis. 2002 Mar 1;34(5):563-71
11807679
Am J Transplant. 2004 Nov;4 Suppl 10:110-34
15504225
Transpl Infect Dis. 2009 Apr;11(2):122-7
19220822
BMC Infect Dis. 2006 Mar 16;6:50
16542444
Clin Infect Dis. 2003 Oct 1;37 Suppl 3:S188-224
12975752
Clin Infect Dis. 2007 Oct 1;45(7):883-93
17806055
Arch Intern Med. 1999 Jun 28;159(12):1301-9
10386506
Chest. 2001 Jan;119(1):169-75
11157600
Antimicrob Agents Chemother. 2008 Jul;52(7):2468-72
18474574
N Engl J Med. 2004 Feb 26;350(9):950-2
14985500
Blood. 2002 Dec 15;100(13):4358-66
12393425
Lancet. 2005 Oct 22-28;366(9495):1435-42
16243088
Clin Infect Dis. 2001 May 1;32(9):1319-24
11303267
Transplantation. 2006 Feb 15;81(3):320-6
16477215
Clin Infect Dis. 2004 Sep 1;39(5):743-6
15356792
Transpl Int. 2003 May;16(5):336-40
12759725
N Engl J Med. 1998 Jun 11;338(24):1741-51
9624195
J Clin Pharmacol. 2009 Feb;49(2):196-204
19033450
J Infect Dis. 2000 Jan;181(1):309-16
10608780
Am J Transplant. 2004 Nov;4 Suppl 10:135-41
15504226
Infect Dis Clin North Am. 2006 Sep;20(3):645-62, vii
16984873
Clin Infect Dis. 2008 Oct 15;47(8):1041-50
18781877
Clin Infect Dis. 2009 Jun 15;48(12):1695-703
19441981
J Infect Dis. 2005 Apr 15;191(8):1350-60
15776383
Clin Infect Dis. 2005 Sep 1;41(5):634-53
16080086
N Engl J Med. 2008 Oct 23;359(17):1766-77
18946062
Infect Dis Clin North Am. 2003 Mar;17(1):113-34, viii
12751263
Blood. 2003 Aug 1;102(3):827-33
12689933
Infect Dis Clin North Am. 2003 Mar;17(1):21-40, vii
12751259
Clin Microbiol Rev. 1999 Apr;12(2):310-50
10194462
Emerg Infect Dis. 2007 Jan;13(1):42-50
17370514
Cancer. 2009 Oct 15;115(20):4745-52
19634156
Infect Dis Clin North Am. 2002 Dec;16(4):875-94, vi
12512185
Clin Infect Dis. 2006 Apr 1;42(7):e61-5
16511748
Clin Infect Dis. 2007 Feb 15;44(4):531-40
17243056
Transplantation. 2008 Sep 27;86(6):791-6
18813103
Clin Infect Dis. 2000 Aug;31(2):545-53
10987719
PLoS Genet. 2008 Jun 20;4(6):e1000101
18566672
Clin Infect Dis. 1992 Sep;15(3):414-21
1520786
Am Rev Respir Dis. 1988 Jun;137(6):1268-74
3144196
Transplantation. 2009 Jul 15;88(1):135-41
19584693
Medicine (Baltimore). 1998 Jul;77(4):246-54
9715729
Bone Marrow Transplant. 2005 Nov;36(10):879-83
16151423
J Infect Dis. 2008 Jul 15;198(2):186-92
18500936
Leukemia. 1997 Oct;11(10):1621-30
9324280
JAMA. 2009 Jun 24;301(24):2578-85
19549975
Int J Med Microbiol. 2002 Oct;292(5-6):391-404
12452285
Clin Infect Dis. 2003 May 1;36(9):1122-31
12715306
Haematologica. 2006 Jul;91(7):986-9
16757415
Transplantation. 2000 Jul 15;70(1):112-6
10919584
Transplant Proc. 2007 Jul-Aug;39(6):2005-7
17692677
Clin Infect Dis. 2009 Jun 15;48(12):1743-51
19435437
Infect Dis Clin North Am. 2001 Sep;15(3):901-52, xi
11570147
Med Mycol. 2005 Dec;43(8):705-10
16422300